Pharmaceutical Robots Market: Size, Share, Trends & Forecast (2024-2029)
The market report offers a detailed analysis segmented by Type (Traditional Robots, Collaborative Pharmaceutical Robots); by Application (Picking and Packing, Inspection of Pharmaceutical Drugs, Laboratory Applications); by Geography (North America, South America, Asia Pacific, Europe, the Middle East, Africa).
Outlook
- The pharmaceutical robots market is estimated to be at USD 249.98 Mn in 2024 and is anticipated to reach USD 366.75 Mn in 2029.
- The pharmaceutical robots market is registering a CAGR of 7.97% during the forecast period of 2024-2029.
- The pharmaceutical robots market involves the use of robotics in pharmaceutical manufacturing, research, and development processes. The market is growing due to increasing demand for automation in the pharmaceutical industry, advancements in robotic technology, and the need for higher productivity and safety standards.
Request a free sample.
Ecosystem
- Participants in the global pharmaceutical robots industry are always developing their strategies to preserve a competitive advantage.
- Companies are focusing on developing robots that are tailored specifically for pharmaceutical applications, such as sterile packaging, precision dosing, and high-throughput screening. (High-throughput screening (HTS) is a scientific discovery method that uses automation, miniaturized assays, and large-scale data analysis to screen large compound libraries for activity against biological targets.)
- Several important entities in the pharmaceutical robots market include Kawasaki Heavy Industries Ltd.; Fanuc Corp.; Kuka AG; ABB Ltd.; YASKAWA Electric Corp.; and others.
Ask for customization.
Findings
| Attributes | Values |
|---|---|
| Historical Period | 2018-2022 |
| Base Year | 2023 |
| Forecast Period | 2024-2029 |
| Market Size (2024) | USD 249.98 Mn |
| Market Size (2029) | USD 366.75 Mn |
| Growth Rate | 7.97% CAGR from 2024 to 2029 |
| Key Segments | Type (Traditional Robots, Collaborative Pharmaceutical Robots); Application (Picking and Packing, Inspection of Pharmaceutical Drugs, Laboratory Applications); Geography (North America, South America, Asia Pacific, Europe, The Middle East, Africa) |
| Key Vendors | Kawasaki Heavy Industries Ltd.; Fanuc Corp.; Kuka AG; ABB Ltd.; YASKAWA Electric Corp. |
| Key Countries | The US; Canada; Mexico; Brazil; Argentina; Colombia; Chile; China; India; Japan; South Korea; The UK; Germany; Italy; France; Spain; Turkey; UAE; Saudi Arabia; Egypt; South Africa |
| Largest Market | Asia Pacific |
Get a free quote.
Trends
- Focus on Ethical AI and Robotics Use: The pharmaceutical industry is increasingly focusing on the ethical use of AI and robotics, ensuring that automation aligns with ethical guidelines and patient safety standards. AstraZeneca has been actively exploring the ethical implications of AI and robotics in drug discovery and manufacturing processes. The company has established internal guidelines to ensure that its use of AI-driven robots aligns with ethical standards, particularly in areas like patient data privacy and algorithmic transparency.
- Sustainability Initiatives: There is a growing emphasis on making pharmaceutical robots more energy-efficient and environmentally friendly. Companies are integrating sustainable practices into their operations. Roche has implemented energy-efficient robotic systems in its manufacturing plants as part of its broader sustainability goals. These robots are designed to minimize energy consumption and reduce the company’s carbon footprint.
- Open-Source Robotics Platforms: The adoption of open-source robotics platforms is gaining traction, allowing for greater collaboration and innovation in the development of pharmaceutical robots. The Open-Source Robotics Foundation (OSRF) collaborates with pharmaceutical companies to develop open-source robotic platforms that can be customized for specific tasks. For instance, Pfizer has leveraged open-source robotics for drug testing and lab automation.
Speak to analyst.
Catalysts
- Rising Demand for Automation: The need for high efficiency, precision, and productivity in pharmaceutical manufacturing is driving the adoption of robots. Automation helps in reducing errors, improving quality, and ensuring compliance with stringent regulatory standards.
- Labor Shortages and Cost Reduction: The growing shortage of skilled labor in the pharmaceutical industry, coupled with the need to reduce operational costs, is prompting companies to invest in robotic solutions. For instance, AstraZeneca has implemented robotic automation in its manufacturing processes to address the shortage of skilled labor and improve efficiency. By doing so, the company has been able to maintain high production levels while significantly reducing labor costs, ensuring continuous operation despite workforce challenges.
- Advancements in Robotic Technology: Technological advancements, such as improved sensors, better human-machine interfaces, and enhanced mobility, are making pharmaceutical robots more versatile and capable of handling complex tasks. ABB’s YuMi robot is a collaborative robot (cobot) designed with advanced sensors, a sophisticated human-machine interface, and enhanced mobility. Its dual-arm configuration allows it to perform complex tasks such as assembling small components, dispensing drugs, and packaging pharmaceutical products with high precision.
Inquire before buying.
Restraints
- High Initial Investment: The significant capital investment required to implement robotic systems in pharmaceutical manufacturing can be a barrier, especially for smaller companies. Boehringer Ingelheim faced significant challenges when it decided to automate its pharmaceutical manufacturing processes with robotics. The initial investment included not just the cost of the robots themselves but also the necessary infrastructure upgrades, such as cleanroom adaptations and advanced software systems.
- Technical Complexity: The integration of robots into existing pharmaceutical processes can be technically challenging, requiring specialized knowledge and expertise. When GSK (GlaxoSmithKline) integrated robotics into its vaccine production line, the company encountered technical challenges related to system compatibility and process integration.
- Regulatory Compliance: Strict regulatory requirements in the pharmaceutical industry pose challenges in the adoption of robots, as companies must ensure that automated processes meet all regulatory standards. For example, Johnson & Johnson faced significant regulatory hurdles when integrating robotic systems into their drug manufacturing process.
Personalize this research.
Hotspot
Explore purchase options.
Table of Contents
| 1.       Introduction 1.1.    Research Methodology 1.2.    Scope of the Study 2.       Market Overview / Executive Summary 2.1.    Global Pharmaceutical Robots Market (2018 – 2022) 2.2.    Global Pharmaceutical Robots Market (2023 – 2029) 3.       Market Segmentation 3.1.    Global Pharmaceutical Robots Market by Type 3.1.1. Traditional Robots 3.1.2. Collaborative Pharmaceutical Robots 3.2.    Global Pharmaceutical Robots Market by Application 3.2.1. Picking and Packing 3.2.2. Inspection of Pharmaceutical Drugs 3.2.3. Laboratory Applications 4.       Regional Segmentation 4.1.    North America 4.1.1. The US 4.1.2. Canada 4.1.3. Mexico 4.2.    South America 4.2.1. Brazil 4.2.2. Argentina 4.2.3. Colombia 4.2.4. Chile 4.2.5. Rest of South America 4.3.    Asia Pacific 4.3.1. China 4.3.2. India 4.3.3. Japan 4.3.4. South Korea 4.3.5. Rest of Asia Pacific 4.4.    Europe 4.4.1. The UK 4.4.2. Germany 4.4.3. Italy 4.4.4. France 4.4.5. Spain 4.4.6. Rest of Europe 4.5.    The Middle East 4.5.1. Turkey 4.5.2. UAE 4.5.3. Saudi Arabia 4.5.4. Rest of the Middle East 4.6.    Africa 4.6.1. Egypt 4.6.2. South Africa 4.6.3. Rest of Africa 5.       Value Chain Analysis of the Global Pharmaceutical Robots Market 6.       Porter Five Forces Analysis 6.1.    Threats of New Entrants 6.2.    Threats of Substitutes 6.3.    Bargaining Power of Buyers 6.4.    Bargaining Power of Suppliers 6.5.    Competition in the Industry 7.       Trends, Drivers and Challenges Analysis 7.1.    Market Trends 7.1.1.    Market Trend 1 7.1.2.    Market Trend 2 7.1.3.    Market Trend 3 7.2.    Market Drivers 7.2.1.    Market Driver 1 7.2.2.    Market Driver 2 7.2.3.    Market Driver 3 7.3.    Market Challenges 7.3.1.    Market Challenge 1 7.3.2.    Market Challenge 2 7.3.3.    Market Challenge 3 8.       Opportunities Analysis 8.1.    Market Opportunity 1 8.2.    Market Opportunity 2 8.3.    Market Opportunity 3 9.       Competitive Landscape 9.1.    Kawasaki Heavy Industries Ltd. 9.2.    Fanuc Corp. 9.3.    Kuka AG 9.4.    ABB Ltd. 9.5.    YASKAWA Electric Corp. 9.6.    Company 6 9.7.    Company 7 9.8.    Company 8 9.9.    Company 9 9.10.  Company 10 |
Know the research methodology.
Pharmaceutical Robots Market – FAQs
1. What is the current size of the pharmaceutical robots market?
Ans. In 2024, the pharmaceutical robots market size is $249.98 Mn.
2. Who are the major vendors in the pharmaceutical robots market?
Ans. The major vendors in the pharmaceutical robots market are Kawasaki Heavy Industries Ltd.; Fanuc Corp.; Kuka AG; ABB Ltd.; YASKAWA Electric Corp.
3. Which segments are covered under the pharmaceutical robots market segments analysis?
Ans. The pharmaceutical robots market report offers in-depth insights into Type, Application, and Geography.